The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer-Reference-Cited by-同舟云学术

The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

Published:2012-04-11 Issue:7 Volume:4 Page:603-616
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Romero Octavio A.¹,Setien Fernando¹,John Sam²,Gimenez‐Xavier Pol¹,Gómez‐López Gonzalo³,Pisano David³,Condom Enric⁴,Villanueva Alberto⁵,Hager Gordon L.²,Sanchez‐Cespedes Montse¹

Affiliation:

1. Genes and Cancer Group, Cancer Epigenetics and Biology Program‐PEBC, Bellvitge Biomedical Research Institute‐IDIBELL, Hospitalet de Llobregat, Barcelona, Spain

2. Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

3. Bioinformatics Unit, Structural Biology and BioComputing Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain

4. Pathology Department, Bellvitge Hospital, Hospitalet de Llobregat, Barcelona, Spain

5. Translational Research Laboratory, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201200236

Reference54 articles.

1. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

2. Expression of BRG1, a human SWI/SNF component, affects the organisation of actin filaments through the RhoA signalling pathway;Asp P;J Cell Sci,2002

3. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

4. Characterization of mammary tumors from Brg1 heterozygous mice

5. A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy;Molecular Therapy;2024-08

2. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features;Virchows Archiv;2024-05-06

3. Esophageal carcinoma with SMARCA4 mutation: a narrative review for this rare entity;Translational Gastroenterology and Hepatology;2024-04

4. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go;International Journal of Molecular Sciences;2024-03-13

5. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance;Biochemical Pharmacology;2024-03